ID27788A - Peptida-peptida antigen tumor yang diperoleh dari siklofilin b - Google Patents

Peptida-peptida antigen tumor yang diperoleh dari siklofilin b

Info

Publication number
ID27788A
ID27788A IDW20002735A ID20002735A ID27788A ID 27788 A ID27788 A ID 27788A ID W20002735 A IDW20002735 A ID W20002735A ID 20002735 A ID20002735 A ID 20002735A ID 27788 A ID27788 A ID 27788A
Authority
ID
Indonesia
Prior art keywords
cyclophilins
tumor
cyclefilin
antigenal
derivatives
Prior art date
Application number
IDW20002735A
Other languages
English (en)
Inventor
Kyogo Itoh
Shinya Gomi
Original Assignee
Kyogo Itoh Cs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyogo Itoh Cs filed Critical Kyogo Itoh Cs
Publication of ID27788A publication Critical patent/ID27788A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IDW20002735A 1998-06-25 1999-06-24 Peptida-peptida antigen tumor yang diperoleh dari siklofilin b ID27788A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17844998 1998-06-25

Publications (1)

Publication Number Publication Date
ID27788A true ID27788A (id) 2001-04-26

Family

ID=16048723

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002735A ID27788A (id) 1998-06-25 1999-06-24 Peptida-peptida antigen tumor yang diperoleh dari siklofilin b

Country Status (14)

Country Link
US (2) US7041297B1 (id)
EP (1) EP1090924B8 (id)
JP (1) JP4413429B2 (id)
KR (1) KR100653590B1 (id)
CN (1) CN1318447C (id)
AT (1) ATE375362T1 (id)
AU (1) AU749544B2 (id)
CA (1) CA2331761A1 (id)
DE (1) DE69937294T2 (id)
ES (1) ES2294844T3 (id)
ID (1) ID27788A (id)
NZ (1) NZ508996A (id)
TW (1) TWI228128B (id)
WO (1) WO1999067288A1 (id)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105306B1 (en) * 2000-08-10 2006-09-12 Trustees Of The University Of Pennsylvania Methods and compositions for modulating somatolactogenic functions
AU7652000A (en) * 1999-09-10 2001-04-17 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Ant-1 as drug target
JP2003523963A (ja) 2000-01-24 2003-08-12 トラスティーズ・オブ・タフツ・カレッジ クリプトスポリジウム・パルヴム関連疾患の治療のためのテトラサイクリン化合物
EP1286954B1 (en) 2000-05-15 2004-04-14 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
AU2001268475A1 (en) * 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
WO2003055441A2 (en) * 2001-08-02 2003-07-10 Paratek Pharmaceuticals, Inc. Medicaments
DK2261249T3 (en) 2002-09-12 2015-02-16 Oncotherapy Science Inc KDR peptides and vaccines comprising the same
WO2005029083A1 (en) * 2003-09-22 2005-03-31 Green Peptide Co., Ltd. Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2301916A3 (en) * 2004-10-25 2011-09-28 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2020417A4 (en) 2006-05-01 2010-10-20 Hitachi Chemical Co Ltd PROSTASIN PARTEPEPTIDE AND ANTI-PROSTASIN ANTIBODY
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
TW200831673A (en) 2006-12-13 2008-08-01 Oncotherapy Science Inc TTK as tumor marker and therapeutic target for lung cancer
MX2009008750A (es) 2007-02-16 2009-08-27 Oncotherapy Science Inc Terapia de vacuna para neovascularizacion coroidal.
TWI434853B (zh) 2007-04-11 2014-04-21 Oncotherapy Science Inc 腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
US20110160280A1 (en) 2007-08-24 2011-06-30 Oncotherapy Science, Inc. Cancer-related genes, cdca5, epha7, stk31 and wdhd1
KR101512885B1 (ko) 2007-09-18 2015-04-16 가부시키가이샤 그린 펩티드 Ｃｔｌ 유도제 조성물
JP4729133B2 (ja) 2007-11-29 2011-07-20 アクテリオン ファーマシューティカルズ リミテッド ホスホン酸誘導体及びｐ２ｙ１２受容体拮抗剤としてのそれらの使用
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
TWI539160B (zh) 2008-12-05 2016-06-21 腫瘤療法 科學股份有限公司 Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
TWI469791B (zh) 2009-02-18 2015-01-21 Oncotherapy Science Inc Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
SG2014013148A (en) 2009-03-18 2014-07-30 Oncotherapy Science Inc Neil3 peptides and vaccines including the same
TWI507204B (zh) 2009-05-26 2015-11-11 Oncotherapy Science Inc Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
TW201136604A (en) 2009-12-14 2011-11-01 Oncotherapy Science Inc TMEM22 peptides and vaccines including the same
KR101872284B1 (ko) 2010-03-11 2018-06-28 온코세라피 사이언스 가부시키가이샤 Ｈｊｕｒｐ 펩티드 및 이를 포함한 백신
ES2613808T3 (es) 2011-07-29 2017-05-26 Oncotherapy Science, Inc. Péptido derivado de ERAP1 y uso del mismo
JP5564730B2 (ja) 2011-08-12 2014-08-06 オンコセラピー・サイエンス株式会社 Ｍｐｈｏｓｐｈ１ペプチドおよびそれを含むワクチン
CN104066746B (zh) 2011-10-28 2017-12-05 肿瘤疗法科学股份有限公司 Topk肽及包含它们的疫苗
EP2872530A4 (en) 2012-07-10 2016-04-06 Oncotherapy Science Inc KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
US9644010B2 (en) 2012-07-10 2017-05-09 Oncotherapy Science, Inc. LY6K epitope peptides for TH1 cells and vaccines containing the same
RU2663350C2 (ru) 2012-09-11 2018-08-03 Онкотерапи Сайенс, Инк. Пептиды ube2t и содержащие их вакцины
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Ｋｎｔｃ２胜肽及含此胜肽之疫苗
CN105658673B (zh) 2013-10-21 2019-07-26 大鹏药品工业株式会社 新型的具有4个连接的ctl表位的肽
EP3981416B1 (en) 2014-08-04 2024-03-20 OncoTherapy Science, Inc. Koc1-derived peptide and vaccine including same
SG10201900835XA (en) 2014-08-04 2019-03-28 Oncotherapy Science Inc Urlc10-derived peptide and vaccine containing same
KR20170040315A (ko) 2014-08-04 2017-04-12 온코세라피 사이언스 가부시키가이샤 Cdca1-유래 펩티드 및 이를 포함하는 백신
BR112018005581A2 (pt) 2015-10-08 2018-10-16 Oncotherapy Science, Inc. peptídeo derivado de foxm1 e vacina incluindo o mesmo
CN112368016A (zh) 2018-06-29 2021-02-12 大鹏药品工业株式会社 抗肿瘤剂及其评价方法
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
US20220098256A1 (en) 2018-11-30 2022-03-31 Tokushima University Therapeutic agent for breast cancer comprising big3-phb2 interaction-inhibiting peptide derived from phb2
JP7522770B2 (ja) 2019-12-26 2024-07-25 大鵬薬品工業株式会社 術後補助療法剤
CN115078727A (zh) * 2022-07-13 2022-09-20 首都医科大学附属北京胸科医院 一种预测癌症免疫治疗效果的标志物、试剂盒与应用
DE102022118517A1 (de) 2022-07-25 2024-01-25 Dennis Reitmeir Liegestützvorrichtung mit drehbaren Griffeinheiten
CN115372618B (zh) * 2022-09-19 2025-01-14 首都医科大学附属北京胸科医院 一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326067A3 (en) * 1988-01-26 1991-04-17 The Du Pont Merck Pharmaceutical Company Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
EP1704868A1 (en) 1992-08-07 2006-09-27 Pharmexa Inc. HLA binding peptides and their uses
JPH09151200A (ja) * 1995-09-29 1997-06-10 Ajinomoto Co Inc ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

Also Published As

Publication number Publication date
EP1090924B1 (en) 2007-10-10
ES2294844T3 (es) 2008-04-01
AU4392699A (en) 2000-01-10
US7368107B2 (en) 2008-05-06
EP1090924A4 (en) 2002-07-10
AU749544B2 (en) 2002-06-27
WO1999067288A1 (en) 1999-12-29
CN1525980A (zh) 2004-09-01
US20060008463A1 (en) 2006-01-12
ATE375362T1 (de) 2007-10-15
WO1999067288A9 (fr) 2000-03-30
DE69937294D1 (de) 2007-11-22
NZ508996A (en) 2003-09-26
US7041297B1 (en) 2006-05-09
HK1067645A1 (en) 2005-04-15
TWI228128B (en) 2005-02-21
CA2331761A1 (en) 1999-12-29
EP1090924B8 (en) 2007-11-21
DE69937294T2 (de) 2008-07-03
KR100653590B1 (ko) 2006-12-04
EP1090924A1 (en) 2001-04-11
KR20010053180A (ko) 2001-06-25
JP4413429B2 (ja) 2010-02-10
CN1318447C (zh) 2007-05-30

Similar Documents

Publication Publication Date Title
ID27788A (id) Peptida-peptida antigen tumor yang diperoleh dari siklofilin b
EP2022800A3 (en) Compositions for the therapy and diagnosis of ovarian cancer
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
BR9907259A (pt) Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
DE60239707D1 (de) Antimikrobielle kationische peptide und diese enthaltende formulierungen
BR9908823A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
EP1194164B8 (en) Prion protein peptides and uses thereof
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
PT738128E (pt) Sistema para inserir material no estroma da cornea
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
EP1762620A3 (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
NZ510154A (en) A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics
NZ331398A (en) Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
EP1103561A4 (en) HLA-A2 RESTRICTED TUMORANTIGEN PEPTIDE DERIVED FROM SART-1
CY1108790T1 (el) Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου